Quarterly Transactions Made in Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). The information is specifically focused on institutions that hold shares of Terns Pharmaceuticals, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 449,148 | 43,305 | 492,453 | 294,668 | 22,341 | 317,009 | 175,444 | |
| Q4 2021 | 651,889 | 131,102 | 782,991 | 184,785 | 885,468 | 1,070,253 | -287,262 | |
| Q1 2022 | 139,090 | 958,460 | 1,097,550 | 761,418 | 58,997 | 820,415 | 277,135 | |
| Q2 2022 | 756,309 | 2,900,329 | 3,656,638 | 3,510,499 | 2,537,987 | 6,048,486 | -2,391,848 | |
| Q3 2022 | 11,012,854 | 9,115,029 | 20,127,883 | 79,545 | 0 | 79,545 | 20,048,338 | |
| Q4 2022 | 13,439,886 | 6,939,082 | 20,378,968 | 703,315 | 0 | 703,315 | 19,675,653 | |
| Q1 2023 | 3,765,260 | 5,061,978 | 8,827,238 | 2,178,305 | 0 | 2,178,305 | 6,648,933 | |
| Q2 2023 | 9,035,614 | 2,820,473 | 11,856,087 | 4,993,294 | 0 | 4,993,294 | 6,862,793 | |
| Q3 2023 | 8,929,428 | 3,243,839 | 12,173,267 | 3,864,238 | 322 | 3,864,560 | 8,308,707 | |
| Q4 2023 | 6,322,845 | 3,253,762 | 9,576,607 | 4,388,172 | 0 | 4,388,172 | 5,188,435 | |
| Q1 2024 | 7,820,880 | 4,742,659 | 12,563,539 | 9,094,683 | 0 | 9,094,683 | 3,468,856 | |
| Q2 2024 | 6,768,820 | 8,629,785 | 15,398,605 | 8,208,954 | 0 | 8,208,954 | 7,189,651 | |
| Q3 2024 | 13,691,918 | 10,109,117 | 23,801,035 | 4,548,254 | 0 | 4,548,254 | 19,252,781 | |